Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02379637 | Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough | PHASE2 | COMPLETED | 70 | — | — | Jan 1, 2015 | Apr 1, 2015 | Jul 11, 2016 | 5 | Canada |
Number of coughs will be measured by a 24-hour ambulatory cough monitoring system for the first 72 hours
| Arm | Type | Description |
|---|---|---|
| A N-acetylcysteine | EXPERIMENTAL | N-acetylcysteine |
| B Placebo | PLACEBO_COMPARATOR | Placebo |
| Name | Type | Description |
|---|---|---|
| N-acetylcysteine | DRUG | - |
| Placebo | DRUG | - |
Inclusion Criteria: * Cold/URTI symptoms occurring no more than 4 days * cough due to a cold or acute viral (URTI) with an onset of no more than 3 days * cough frequency with specified cut-off Exclusion Criteria: * A subchronic, or chronic cough (cough duration \> 2 months) due to any condition o...